Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Total Flavonoids of Propolis Dropping Pill in Angina Pectoris: A Randomized, Double-Blind, Placebo-Controlled Multi-Centered Clinical Trial on Efficacy and Safety.

NCT01453582 is registered in ClinicalTrials.gov with Shanghai Greenvalley Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT01453582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01453582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Total Flavonoids of Propolis Dropping Pill in Angina Pectoris: A Randomized, Double-Blind, Placebo-Controlled Multi-Centered Clinical Trial on Efficacy and Safety.
Lead sponsor
Shanghai Greenvalley Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2011
Completion date
September 30, 2015
Enrollment
478 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

stable angina pectoris